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Abstract Some enzymatic and physicocbemical properties of a 
human ubiquitin-specific isopeptidase are reported. The enzyme 
was purified to homogeneity from red blood cells and its specific- 
ity towards polymeric ubiquitin substrates uggests a de-ubiquiti- 
nating activity capable of cleaving 'head-to-tail' polyUb chains as 
well as isoamide 'branched' Ub dimers. KM values show a 10 fold 
preference for the cleavage of branched Ub dimers over head-to- 
tail Ub dimers. The enzymatic activity can be strongly inhibited 
by various peptides containing either of the cleavage site se- 
quences found in Ub polymers, but not by unrelated peptides. The 
enzyme is monomeric under reducing conditions and exhibits a 
globular shape with an average diameter of 9 nm, an S2o,w value 
of 5.2 S and a molar mass of 110 kDa -+ 10%. Because the 
enzyme cleaves both peptide-linked and isopeptide-linked Ub 
moieties from substrates, we propose to name it de-ubiquitinase 
rather than isopeptidase. 
Key words: De-ubiquitinating enzyme; Ubiquitin-specific 
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I. Introduction 
During ubiquitin-dependent protein degradation, proteins 
are marked for breakdown by covalent ligation to ubiquitin 
(Ub), forming 'conjugates' of multiubiquitin chains in which 
the carboxyl-terminal Gly-76 of one (or more) Ub molecules in 
the chain is joined to one (or more) internal Lys of targeted 
proteins via an isoamide bond. In the same way, each ubiquitin 
molecule can be ubiquitinated on its own Lys-48 to form 
'branched' multiubiquitin chains [1,2]. Target proteins ligated 
to multiubiquitin chains are then programmed for degradation 
through the proteasome, an ATP-dependent 26 S protease 
complex [3,4]. 
Ubiquitin is expressed from polyubiquitin genes and ubiq- 
uitin fusion genes leading to 'head-to-tail' transient polyubiq- 
uitin and fusion proteins, which are processed to monomeric 
Ub. In yeast, various processing proteases cleave in vivo the 
peptide bonds Gly-76-Met-1 of head-to-tail polyubiquitins a
well as Gly-76-X bonds in ubiquitin fusions that lack the head- 
to-tail Ub-Ub motif [5,6]. Two types of Ub C-terminal isopep- 
*Corresponding author. Fax: (41) (22) 347 3433. 
Abbreviations: Ub, ubiquitin; polyUb, 'head-to-tail' polyubiquitin; 
multiUb, 'branched' polyubiquitin; Ac, acetyl; (Y), tyrosine residue 
absent from Ub sequence but placed in the NH2-terminal position of 
peptides to allow them to be coupled to protein carriers in further 
studies. 
tidase activities have been postulated [7,8]: (i) for the release of 
Ub units bond to a Lys residue of the protein substrate; and 
(ii) for the disassembling of multiUb chains during or after 
proteolysis of the targeted protein. Many Ub C-terminal 
isopeptidases and hydrolysases have been described [5,6,9-12] 
but their possible involvement in the above processes have not 
yet been fully elucidated. 
We wish to describe here the functional properties of an 100 
kDa 'isopeptidase' from human erythrocyte lysate which was 
purified to homogeneity and which, unexpectedly, cleaves in 
vitro both head-to-tail and branched polymeric Ub substrates, 
in contrast to the 30 kDa ubiquitin C-terminal hydrolysase. 
2. Materials and methods 
2.1. Materials 
Outdated human blood samples from the Central Hematology Lab- 
oratory of the Geneva Canton Hospital was the source of the 100 kDa 
de-ubiquitinating enzyme. Ubiquitin-derived peptides, i.e. the C-termi- 
nal decapeptide (Y)-H68-L-V-L-R-L-R-G-G76, the 20-residue long 
head-to-tail peptide, H68-L-V-L-R-L-R-G-G76-McQ-I-F-V-K-T-L-T- 
G-K., and the isopeptide (G76 K48): 
(Y) -H-L-V-L-R-L-R-G-G76 
I 
Y -Ac-R42-L- I- F-A-G-K48-Q-L-E-D-G-Rs4 
were synthesized according to standard techniques [13] and purified by 
reversed phase HPLC on a column (21 x 250 mm) of Nucleosil C8 
(5 Bm particle size), using as eluants increasing concentrations of ace- 
tonitrile in 0.1% (w/v) trifluoroacetic a id. Data (not shown) obtained 
from electrospray mass spectrometry, amino acid analysis and auto- 
mated Edman degradation were consistent with the proposed struc- 
tures. The analyses of peptides produced upon tryptic digestion of the 
branched peptide showed the presence of 
GG 
I 
L IFAGKQLEDGR 
thus confirming the isoamide linkage of Gly to Lys. Peptide concentra- 
tions were determined by amino acid analysis. 
2.2. Enzyme purification from outdated human blood 
The isopeptidase fraction (containing the 100 and 30 kDa proteins) 
was purified from an erythrocyte lysate as described by Pickart and 
Rose [14] with some modifications: fraction II eluted from DE-52 
(Whatman) was diluted 1 : 1 with buffer D (20 mM Tris-HCl, pH 7.2, 
0.2 mM DTT) and recycled overnight on an ubiquitin-Sepharose col-
umn previously equilibrated at 4°C in STD buffer (50 mM Tris-HC1, 
pH 7.2, 0.1 mM EDTA, 0.2 mM DTT, 5% glycerol). The column was 
successively washed with 3 vols. STD buffer, 3 vols. STD buffer + 0.5 
M KCI, and 3 vols. STD buffer. The isopeptidase fraction was eluted 
with 5 vols. ISO buffer (50 mM Tris-HCl, pH 9.0, 0.1 mM EDTA, 10 
mM DTT, 5% glycerol). 
The isopeptidase fraction (30 ml) was concentrated ona small DE-52 
column (0.3 ml) equilibrated in buffer C (20 mM Tris-HCl, pH 7.2), 
washed with buffer C and eluted with buffer C containing 300 mM 
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NaCI. Usually, 30 ml were concentrated to less than 2 ml. The concen- 
trated protein solution was passed through aSuperose 12 column equil- 
ibrated in PBS (pH 7.4) to separate the 100 kDa form from the 30 kDa 
C-terminal hydrolase. Both proteins were collected, diluted 1:1 with 
buffer C, and concentrated asdescribed above. Glycerol was added to 
a final concentration of 30% and proteins were kept at -20°C. 
2.3. Enzyme substrates 
The Manduca polyubiquitin cDNA containing 9 repetitive coding 
units of the Ub gene (a generous gift from Dr. L.M. Schwartz, Univer- 
sity of Massachusetts, USA) was inserted into pBluescript SK(-) vector 
(Stratagene); the dimeric form (Ub2) was subcloned by digestion with 
BgllI followed by direct religation, and recloning into pKK223-3 vector 
(Pharmacia). Transfection of E. coli SBI cells and over-expression led 
to the accumulation of Ub2 which was purified on DE-52 in 25 mM 
Tris-HC1, 1 mM EDTA buffer, pH 7.5, and Mono-S column (Pharma- 
cia) in 50 mM Na-acetate buffer, pH 4.0. No contaminating proteins 
were detected by silver staining of an overloaded gel. The nonameric 
polyUb (Ub9) was prepared as for the dimer and was found to be 
slightly contaminated by a series of polyUb proteins (octa-, hepta-, 
penta-, tetramers to monomer of Ub). The purified nonamer was 
cleaved by CNBr, and a single 8.5 kDa band was apparent on SDS- 
PAGE. Lys C digestion, in the presence of 8 M urea, followed by 
blotting over PVDF membrane and Edman degradation of selected 
peptides, confirmed the presence of the head to tail peptide, 
E64STLHLVLRLRGG76M1QIFVK 6(data not shown). 
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Fig. 2. Coomassie blue stained SDS-PAGE profiles of digestion mixtures (20 ,ul) at 37°C containing 2/.tg (6/IM) of 'head-to-tail' ( anes 1~l) and 
'branched' imeric Ub (lanes 6-9) and 0.1 pg (0.05/IM) of 100 kDa isopeptidase for the period of time indicated. Lane 5, molecular weight markers, 
the sizes of which are shown at the right. 
The branched i-ubiquitin was a generous gift from Dr. C.M. Pickart 
(University of Buffalo, USA); it was synthesized using recombinant 
E2-25 kDa, an enzyme which links Ub only by isopeptide bonds involv- 
ing K-48 and G-76 [15]. 
Protein concentrations were determined by the micro BCA assay 
(Pierce). 
2.4. Labelling of substrates 
In order to quantitate substrates and products for KM value determi- 
nation, head-to-tail and branched Ub dimers (50/tg each) were labelled 
with 0.5 mCi of 1251 (Amersham) using the Iodogen kit from Pierce. 
After desalting, the specific activity was calculated to be 3.7 x 10 7 cpm/  
pg for the head-to-tail Ub dimer and 3.9 × 10 7 cprn/pg for the branched 
Ub dimer. 
2.5. Enzymatic assays 
The reaction mix (20 pl) contained 1pg (3/tM) of head-to-tail Ub 
dimer and 0.2pg (0.1/IM) of 100 kDa isopeptidase in 50 mM Tris-HCl 
buffer, pH 7.2, containing 1mM DTT. The mixture was incubated for 
1 h at 37°C and the reaction was stopped by adding 200 pl of0.1% TFA. 
The sample was analyzed on a 7 pm RP300 column (2.1 × 30 mm; 
Brownlee Aquapore). The initial conditions were 0.1% TFA, 10% ace- 
tonitrile and the gradient was from 10% to 50% acetonitrile in 45 min 
with a flow rate of 300 pl/min. 
2.5.1. SDS Tris-Tricine gel for K M determination. Enzymatic 
reactions (20 pl) were carried out at substrate concentrations ranging 
from 0.5 to 4pg (1.5 12/tM) and various digestion times from 0 to 30 
rain; digestion mixtures were analyzed by SDS Tris-Tricine gel [16]. In 
each case, an average of 2 × 105 cpm of labelled substrate was added 
per/.tg of unlabelled substrate. The reaction was stopped by adding 20 
/~1 of SDS sample buffer and the sample was kept on ice. To facilitate 
gel band identification, unlabelled head-to-tail dimer and unlabelled 
monomer (1/tg each) were added to the samples prior to boiling and 
loading onto the gel. After Coomassie blue stain, bands were excised 
¢:-_ 
Fig. 1. (A) Silver stained SDS-PAGE of purified 100 kDa isopeptidase and 30 kDa C-terminal hydrolase. Lanes: (1) pH 9 eluate from Ub-Sepharose 
column; (2) purified 100 kDa isopeptidase; (3) purified 30 kDa C-terminal hydrolase; (4) broad molecular weight markers (kDa). (B) Coomassie blue 
stained SDS-PAGE profiles of digestion mixtures (10 pl) of polyUb chains with 100 kDa isopeptidase and C-terminal hydrolase. 2.5/tg of dimers 
(I 5 pM), 4/tg of nonamer (5 pM) were used in the presence and the absence of 0. I pM of enzymes; digestion time 60 min at 37°C. Slots are numbered 
1-11 at the bottom of the figure. For further details, see section 2. 
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Table 1 
Inhibition of the 100 kDa isopeptidase with synthetic peptides 
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Substrate 
ratio 
inhib: 
subs 
"head-to-tail" 1:1 
dimer 
N~CN(~C 10:1 
40:1 
• branched" dimer 
~ 2:1 
o 
N(~)C 20:1 
Peptide inhibitors 
~L ,  ...=Din ,,,,4 GTsGTe motilin secretin 
++ 
++ 
+ 
++ 
++ = high inhibition (70-100 %) 
+ = medium inhibition (20-70 %) 
= no inhibition (<20 %) 
n.d. -- not determined 
++ 
++ 
+ 
++ 
+ 
++ 
n.d. 
n.d. 
rl.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
1 Ub "branched" peptide 
Ub "head-to-tail" peptide 
Ub "tail" peptide 
G75G76 Glycylglycine 
and 125I radioactivity was counted on a Beckman Gamma 4000 appara- 
tus. For each experiment, a control of substrate incubated without 
enzyme was loaded onto the gel and counted as described. Each concen- 
tration or time point was run in triplicate. Synthetic Ub-derived pep- 
tides described above were used as competitive inhibitors at molar 
ratios ranging from 1 : 1 to 40 : 1 relative to substrate concentration. KM
values were calculated using Lineweaver-Burk plots. 
3. Results 
No cross-contamination between the 100 kDa enzyme and 
the 30 kDa enzyme was visible, as revealed on the overloaded 
gel (Fig. 1A). Two minor fast migrating bands in the 100 kDa 
preparation are visible and reflect degradation products reac- 
tive with an antibody to the 100 kDa band. When subjected to 
analytical ultracentrifugation n 50 mM phosphate buffer, pH 
7.2, the high M r enzyme fraction exhibited a S20.w value of 5.2 
S and a molar mass of 110 kDa -+ 10%. Negative staining elec- 
tron microscopy revealed small globules with an average diam- 
eter of 9 nm. For a spherical protein of Mr 100,000, a diameter 
of 7 nm is predicted [17], a figure in good agreement with 
experimental data. The enzyme fraction behaves as a monomer 
under reduced conditions (1 mM DTT), and spontaneously 
forms heavy aggregates upon reoxidation under the electron 
microscope (data not shown). 
The results are illustrated in Fig. 1B; enzymes were added to 
substrates in a molar ratio of 1 : 140. The 30 kDa Ub specific 
C-terminal hydrolase was used as a control: it was unable to 
cleave peptide bonds in head-to-tail Ub dimers or nonamers 
(lanes 3, 9) and barely cleaved a branched imeric Ub (lane 6). 
This is in agreement with earlier eports [18,19] which suggested 
that the C-terminal hydrolase was able to specifically split G- 
76-X bonds in Ub fusion proteins [18] but not in head-to-tail 
Ub dimers [20]. In contrast, he 100 kDa isopeptidase was able 
to cleave both isopeptidic bond G76-K48 in dimeric branched 
Ub (lane 5) and G76-M 1 peptide bonds in head-to-tail Ub2 and 
Ub 9 polymers (lanes 2 and 8), leading to the accumulation of
the monomeric Ub unit. Amino acid sequence determination 
of the monomeric Ub recovered from gels in both cases indi- 
cated the expected N-terminal sequence M-Q-I-F-V of Ub. 
The timecourse study (Fig. 2) shows that the branched 
dimeric Ub was readily cleaved to the extent of about 80% after 
5 min and 90% after 20 min, whereas no cleavage was apparent 
at 5 min and no more than 50% cleavage occurred after 20 min 
in the case of the head-to-tail dimeric Ub. 
The KM values for both substrates are markedly different, 
and were determined to be 2 x 10-6__. 0.3 x 10 .6 M for the 
branched imeric conjugate and 1.5 x 10 -5 + 0.5 x 10 -5 M in 
the case of the head-to-tail dimeric Ub. 
The 100 kDa isopeptidase was unable to cleave small syn- 
thetic peptides encompassing the Ub sequence around the 
isoamide bond GT~K48, or around the head-to-tail bond G76- 
M~. The latter peptides and the C-terminal decapeptide (Ub 
tail) were then used as competitive inhibitors of the cleavage of 
dimeric Ub substrates (Table 1). Both branched and head-to- 
tail peptides were strong inhibitors, while the C-terminal de- 
capeptide was less inhibitory. In contrast, the C-terminal gly- 
cylglycine dipeptide (G75-G76) was not inhibitory at all, as were 
two Ub unrelated peptides, motilin and secretin, used as con- 
trols. No significant differences in the degree of inhibition me- 
diated by the branched peptide as compared to the head-to-tail 
peptide was apparent, as both peptides mimick a substrate of 
the enzyme. 
4. Discussion 
In 1992, Hadari et al. [11] described the isolation of an 100 
kDa isopeptidase T from human red blood cells which acts as 
a Ub C-terminal enzyme that cleaves high M r branched 
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multiUb chains; it, however, did not further disassemble 
medium-sized multiUb conjugates, nor did it cleave isoami- 
de linkages between branched multiUb chains and target 
proteins. 
Using characterized Ub substrates, we demonstrate h re that 
the 100 kDa isopeptidase, isolated as described above from 
human red blood cells, is able to preferentially cleave the 
isoamide bond (G76-K4s) in branched Ub dimers into the mon- 
omeric Ub moiety, and also that this enzyme cleaves head-to- 
tail (G76-M0 nonameric or dimeric polyUb chains into the 
monomeric Ub moiety, though at a reduced rate. This Ub 
specific enzyme does not seem to exhibit a highly restricted 
isopeptidase activity but rather behaves as a Ub specific de- 
ubiquitinase. 
Both peptide analogs (G76-M 1 head-to-tail and Gv6-K48 
branched peptides) are not cleaved at all by the isopeptidase but 
behave as efficient inhibitors (Table 1). It can be hypothesized 
that the small peptide analogs bind to the active center of the 
enzyme but that they are most likely too small for the enzyme 
to induce a distortion of the substrate that would force it to- 
ward a stabilized 'transition state'. 
The 100 kDa de-ubiquitinase r sembles the recently de- 
scribed yeast DOA4 gene product, and perhaps the human tre-2 
oncogene product [12]. Indeed, DOA4 was reported to cleave 
both peptide-linked and isopeptide-linked Ub moieties from 
substrates. In yeast, several de-ubiquitinating enzymes are 
known, of which their functional diversity may reflect differ- 
ences in their substrate specificity or in their role within the Ub 
pathway. De-ubiquitination reactions could be very important 
in (i) Ub precursor processing into the monomeric Ub moiety, 
(ii) in removing Ub from branched multiUb substrate conju- 
gates before proteolysis, or (iii) in the proteolytic steps of the 
degradation pathway. It is not known whether the 100 kDa 
de-ubiquitinase d scribed in this report may be involved in all 
three reactions. We show, however, that head-to-tail G76-M l
Ub polymers can be cleaved in vitro by the enzyme, in contrast 
to one Ub processing protease from yeast [6], which was active 
in vivo but inactive in vitro; it remains to be demonstrated 
whether the enzyme described here can also mediate such Ub 
precursor processing in vivo. 
Acknowledgements: The authors wish to thank Dr. C. Pickart (Univer- 
sity of Buffalo, USA) for her gift of 'branched' imeric Ub, Dr. L.M. 
Schwarz (University of Massachusetts, USA) for his gift of Manduca 
polyUb cDNA, Dr. J. Engel (University of Basel, Switzerland) for 
electron microscopy and analytic ultracentrifugation data, and Drs. K. 
Rose (University of Geneva) and L.-A. Savoy (M-Scan S.A., Geneva) 
for mass spectrometric analyses. This work was supported in part by 
Grants 3100-033658.92 and 5002-0388919 from the Swiss National 
Science Foundation. 
References 
[1] Chau, V., Tobias, J.W., Bachmair, A., Marriot, D., Ecker, D.J., 
Gonda, D.K. and Varshavsky, A. (1989) Science 243, 1576-1583. 
[2] Chen, Z.J. and Pickart, C.M. (1990) J. Biol. Chem. 265, 1835- 
1842. 
[3] Hershko, A., Ciechanover, A., Elias, S. and Heller, H. (1983) 
J. Biol. Chem. 258, 8206-8214. 
[4] Hershko, A. (1991) Trends Biochem. Sci. 16, 265-268. 
[5] Baker, R.T., Tobias, J.W. and Varshavsky, A. (1992) J. Biol. 
Chem. 267, 3364-3375. 
[6] Tobias, J.W. and Varshavsky, A. (1991) J. Biol. Chem. 266, 2021 
2028. 
[7] Rose, I.A. and Warms, J.V.B. (1983) Biochemistry 22, 4234-4237. 
[8] Wilkinson, K.D., Pohl, J., Boss, J.M., Lee, K., Duerksenhughes, 
P. and Deshpande, S. (1989) Science 246, 670-673. 
[9] Zhang, N., Wilkinson, K.D. and Bownes, M. (1993) Dev. Biol. 
157, 214-223. 
[10] Eytan, E., Armon, T., Heller, H., Beck, S. and Hershko, A. (1993) 
J. Biol. Chem. 268, 4668~,674. 
[11] Hadari, T., Warms, J.V.B., Rose, I.A. and Hershko, A~ (1992) 
J. Biol. Chem. 267, 719-727. 
[12] Papa, F.R. and Hochstrasser, M. (1993) Nature 366, 313 319. 
[13] Plau6, S., Miiller, S. and van Regelmortel, M.H.V. (1989) J. Exp. 
Med. 169, 1607-1617. 
[14] Pickart, C.M. and Rose, I.A. (1985) J. Biol. Chem. 260, 7903-7910. 
[15] Chen, Z.J., Niles, E.G. and Pickart, C.M. (1991) J..Biol. Chem. 
266, 15698-15704. 
[16] Sch/igger, H. and von Jagow, G. (1987) Anal. Biochem. 166, 368 
379. 
[17] Engel, J. and Furthmayr, H. (1987) Methods Enzymol. 145, 3-78. 
[18] Liu, C.C., Miller, H.I., Kohr, W.J. and Silber, J.I. (1989) J. Biol. 
Chem. 264, 331 338. 
[19] Wilkinson, K.D., Deshpande, S. and Larsen, C.N. (1992) Bio- 
chem. Soc. Trans. 20, 631-637. 
[20] Pickart, C.M. and Rose, I.A. (1986) J. Biol. Chem. 261, 10210 
10217. 
